This is a snippet of the transcript, sign up to read more.
Yes, I will present this as we communicated with our employees and the market. The family was not interested in a private equity type acquisition. I worked at KPMG, and the company I primarily audited averaged over 15 acquisitions a year. As a senior manager, I handled purchase price accounting and saw projections and plans upfront, as well as post-acquisition outcomes. There was almost no desire for KZValve to be sold to private equity, as they didn't want to follow that typical path. The value IDEX brought was significant, having owned Banjo since 2006. They demonstrated their approach as an owner. Their goal is to buy organizations, focusing on acquiring people, technical staff, and maintaining a good brand with great people. They aim to retain individuals and grow the business. In full disclosure, I couldn't stay at KZValve because I also owned one of our vendors.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research